Acousia Therapeutics: Acousia Therapeutics: First patient with age-related hearing loss treated with ACOU085

ACOU085, the lead candidate from hearing loss company Acousia Therapeutics, has been administered to the first patient with age-related hearing loss (presbycusis) in a Phase 1b clinical study in Germany. The pre-screening of patients matching the comprehensive in/exclusion criteria for the ongoing trial is almost c...